Evidence map›Paper›PMID 34170381›Full record

ArticleCancer immunology, immunotherapy : CII2021

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo.

Anja Tatjana Teck, Sabrina Urban, Petra Quass, Annika Nelde, Heiko Schuster, Anne Letsch, Antonia Busse, Juliane Sarah Walz, Ulrich Keilholz, Sebastian Ochsenreither

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Anja Tatjana TeckDepartment of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-9563-0341
Sabrina UrbanDepartment of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany.
Petra QuassDepartment of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany.
Annika NeldeDepartment of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany.
Heiko SchusterDepartment of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany.
Anne LetschDepartment of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany.
Antonia BusseDepartment of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany.
Juliane Sarah WalzDepartment of Hematology and Oncology, University of Tübingen, Tübingen, Germany.
Ulrich KeilholzCharité Comprehensive Cancer Center, Charitéplatz 1, 10117, Berlin, Germany.
Sebastian OchsenreitherDepartment of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany. Sebastian.ochsenreither@charite.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34170381
PMCPMC8423697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.